List of Tables
Table 1. Global Viral Vectors Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Retro Viral Vectors
Table 3. Key Players of Adeno-associated Virus Vectors
Table 4. Key Players of Other Viral Vectors
Table 5. Global Viral Vectors Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Viral Vectors Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Viral Vectors Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Viral Vectors Gene Therapy Market Share by Region (2019-2024)
Table 9. Global Viral Vectors Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Viral Vectors Gene Therapy Market Share by Region (2025-2030)
Table 11. Viral Vectors Gene Therapy Market Trends
Table 12. Viral Vectors Gene Therapy Market Drivers
Table 13. Viral Vectors Gene Therapy Market Challenges
Table 14. Viral Vectors Gene Therapy Market Restraints
Table 15. Global Viral Vectors Gene Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Viral Vectors Gene Therapy Market Share by Players (2019-2024)
Table 17. Global Top Viral Vectors Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors Gene Therapy as of 2023)
Table 18. Ranking of Global Top Viral Vectors Gene Therapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Viral Vectors Gene Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Viral Vectors Gene Therapy Product Solution and Service
Table 22. Date of Enter into Viral Vectors Gene Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Viral Vectors Gene Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Viral Vectors Gene Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global Viral Vectors Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Viral Vectors Gene Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global Viral Vectors Gene Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Viral Vectors Gene Therapy Revenue Market Share by Application (2019-2024)
Table 30. Global Viral Vectors Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Viral Vectors Gene Therapy Revenue Market Share by Application (2025-2030)
Table 32. North America Viral Vectors Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Viral Vectors Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Viral Vectors Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Viral Vectors Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Viral Vectors Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Viral Vectors Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Viral Vectors Gene Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Viral Vectors Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Viral Vectors Gene Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Viral Vectors Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Viral Vectors Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Viral Vectors Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Viral Vectors Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Viral Vectors Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Viral Vectors Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Amgen Company Detail
Table 48. Amgen Business Overview
Table 49. Amgen Viral Vectors Gene Therapy Product
Table 50. Amgen Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 51. Amgen Recent Development
Table 52. Novartis Company Detail
Table 53. Novartis Business Overview
Table 54. Novartis Viral Vectors Gene Therapy Product
Table 55. Novartis Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 56. Novartis Recent Development
Table 57. Orchard Therapeutics Company Detail
Table 58. Orchard Therapeutics Business Overview
Table 59. Orchard Therapeutics Viral Vectors Gene Therapy Product
Table 60. Orchard Therapeutics Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 61. Orchard Therapeutics Recent Development
Table 62. Spark Therapeutics Company Detail
Table 63. Spark Therapeutics Business Overview
Table 64. Spark Therapeutics Viral Vectors Gene Therapy Product
Table 65. Spark Therapeutics Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 66. Spark Therapeutics Recent Development
Table 67. Agc Biologics Company Detail
Table 68. Agc Biologics Business Overview
Table 69. Agc Biologics Viral Vectors Gene Therapy Product
Table 70. Agc Biologics Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 71. Agc Biologics Recent Development
Table 72. Anges Company Detail
Table 73. Anges Business Overview
Table 74. Anges Viral Vectors Gene Therapy Product
Table 75. Anges Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 76. Anges Recent Development
Table 77. Bluebird Bio Company Detail
Table 78. Bluebird Bio Business Overview
Table 79. Bluebird Bio Viral Vectors Gene Therapy Product
Table 80. Bluebird Bio Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 81. Bluebird Bio Recent Development
Table 82. Jazz Pharmaceuticals Company Detail
Table 83. Jazz Pharmaceuticals Business Overview
Table 84. Jazz Pharmaceuticals Viral Vectors Gene Therapy Product
Table 85. Jazz Pharmaceuticals Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 86. Jazz Pharmaceuticals Recent Development
Table 87. Dynavax Technologies Company Detail
Table 88. Dynavax Technologies Business Overview
Table 89. Dynavax Technologies Viral Vectors Gene Therapy Product
Table 90. Dynavax Technologies Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 91. Dynavax Technologies Recent Development
Table 92. Biogen Company Detail
Table 93. Biogen Business Overview
Table 94. Biogen Viral Vectors Gene Therapy Product
Table 95. Biogen Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 96. Biogen Recent Development
Table 97. Sarepta Therapeutics Company Detail
Table 98. Sarepta Therapeutics Business Overview
Table 99. Sarepta Therapeutics Viral Vectors Gene Therapy Product
Table 100. Sarepta Therapeutics Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 101. Sarepta Therapeutics Recent Development
Table 102. Gilead Sciences Company Detail
Table 103. Gilead Sciences Business Overview
Table 104. Gilead Sciences Viral Vectors Gene Therapy Product
Table 105. Gilead Sciences Revenue in Viral Vectors Gene Therapy Business (2019-2024) & (US$ Million)
Table 106. Gilead Sciences Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Viral Vectors Gene Therapy Market Share by Type: 2023 VS 2030
Figure 3. Retro Viral Vectors Features
Figure 4. Adeno-associated Virus Vectors Features
Figure 5. Other Viral Vectors Features
Figure 6. Global Viral Vectors Gene Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Viral Vectors Gene Therapy Market Share by Application: 2023 VS 2030
Figure 8. In Vivo Case Studies
Figure 9. Ex Vivo Case Studies
Figure 10. Viral Vectors Gene Therapy Report Years Considered
Figure 11. Global Viral Vectors Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Viral Vectors Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Viral Vectors Gene Therapy Market Share by Region: 2023 VS 2030
Figure 14. Global Viral Vectors Gene Therapy Market Share by Players in 2023
Figure 15. Global Top Viral Vectors Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors Gene Therapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Viral Vectors Gene Therapy Revenue in 2023
Figure 17. North America Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Viral Vectors Gene Therapy Market Share by Country (2019-2030)
Figure 19. United States Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Viral Vectors Gene Therapy Market Share by Country (2019-2030)
Figure 23. Germany Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Viral Vectors Gene Therapy Market Share by Region (2019-2030)
Figure 31. China Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Viral Vectors Gene Therapy Market Share by Country (2019-2030)
Figure 39. Mexico Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Viral Vectors Gene Therapy Market Share by Country (2019-2030)
Figure 43. Turkey Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Viral Vectors Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Amgen Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 46. Novartis Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 47. Orchard Therapeutics Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 48. Spark Therapeutics Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 49. Agc Biologics Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 50. Anges Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 51. Bluebird Bio Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 52. Jazz Pharmaceuticals Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 53. Dynavax Technologies Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 54. Biogen Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 55. Sarepta Therapeutics Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 56. Gilead Sciences Revenue Growth Rate in Viral Vectors Gene Therapy Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed